Ada serves as vice president of medical affairs at Latigo Biotherapeutics, where she leads the company’s global medical affairs strategy for its portfolio of innovative non-opioid therapies for acute and chronic pain. As a physician-scientist with over 25 years of clinical and biopharmaceutical experience, Ada supports the advancement of Latigo’s pipeline from development through commercialization, translating scientific innovation into clinical impact.

Before joining Latigo, Ada held senior medical affairs leadership roles at Amgen and Horizon Therapeutics. At Horizon Therapeutics, she established and led the company’s imaging capability across multiple rare disease programs. Following Horizon’s acquisition by Amgen, she served as the global medical affairs lead where she directed global medical strategy for a blockbuster therapy while supporting the development of pipeline assets.

Ada earned her Doctor of Medicine from Northwestern University Feinberg School of Medicine and completed a diagnostic radiology residency at Brigham and Women’s Hospital, Harvard Medical School, followed by a fellowship in musculoskeletal radiology at The University of Chicago, Pritzker School of Medicine.